491 afleveringen
After presenting data at ESMO this past weekend, Tango Therapeutics believes that adding PRMT5 to RAS inhibitors represents the 'next chapter' in today's pancreatic cancer revolution (and beyond)
29-10-2026 | 21 Min.President and CEO Malte Peters summarizes the ESMO data for vopemetistat, which was in second and third line pancreatic cancer in combination with daraxonrasib, and discusses plans for a phase 3 in first line (plus the regulatory path for later lines as well). Additionally, he discusses using PRMT5 inhibition in lung cancer and GBM.At its R&D Day in London today, Gubra provided updates on obesity assets licensed to AbbVie and Boehringer Ingelheim, as well as highlighted its lead internal program UCN2
27-10-2026 | 22 Min.CEO Markus Rohrwild and CDMO Thomas Langenickel provide an update on the company's peptide based drug development side, as well as venture and CRO arms.London based IMU Biosciences announced today that it will use its immune system profiling platform with 80,000 blood samples from UK Biobank to create a large-scale picture of the human immune system
19-10-2026 | 13 Min.CEO John Baker describes how the project, done in collaboration with Ultima Genomics and Waters Corporation, will give researcher a tool to better understand the immune system. He also describes how IMU's blood sample based system works, and how it has been used for things such as to better understand which patients will respond to cancer immunotherapies.Oxford, UK based OMass Therapeutics announced a $310M series C today, advancing its small molecule platform, including the lead MC2 (melanocortin-2) receptor antagonist that is in phase 1
15-10-2026 | 11 Min.CEO Ros Deegan describes the raise and the new investors that it brings into the company, and updates us on the company's pipeline progress.At Dana-Farber Cancer Institute in Boston, President & CEO Ben Ebert and Professor and Investigator Cigall Kadoch discuss the latest trends in cancer research
14-10-2026 | 19 Min.They discuss recent advances, what's ahead, Cigall's work in epigenetics, and how a new hospital will be purpose built for patients with the best new technologies in clinical research.
Luister naar BiotechTV - News, Biotech Hangout en vele andere podcasts van over de hele wereld met de radio.net-app
Ontvang de gratis radio.net app
- Zenders en podcasts om te bookmarken
- Streamen via Wi-Fi of Bluetooth
- Ondersteunt Carplay & Android Auto
- Veel andere app-functies
Ontvang de gratis radio.net app
- Zenders en podcasts om te bookmarken
- Streamen via Wi-Fi of Bluetooth
- Ondersteunt Carplay & Android Auto
- Veel andere app-functies
BiotechTV - News
download de app,
luisteren.
Netherlands
